 GAITHERSBURG, Md., April 19, 2021 GLOBE NEWSWIRE -- OpGen, Inc. Nasdaq: OPGN announced today that its strategic collaboration with the New York State Department of Health DOH to develop a state-of-the-art solution to detect, track, and manage antimicrobial-resistant infections at healthcare institutions statewide is being extended beyond the second-year expansion phase by another six months through September 30, 2021. 